1. Status Quo of Hybrid Coronary Revascularization for Multi-Vessel Coronary Artery Disease 
Ralf E. Harskamp, MD, Zhe Zheng, MD, PhD, John H. Alexander, MD, MHS, Judson B. Williams, MD, MHS, Ying Xian, MD, PHD, Michael E. Halkos, MD, J. Matthew Brennan, MD, MPH, Robbert J. de Winter, MD, PhD, Peter K. Smith, MD, Renato D. Lopes, MD, PhD 
The Annals of Thoracic Surgery 
Volume 96, Issue 6, Pages (December 2013)
DOI: /j.athoracsur
Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

2. Fig 1
Rates of vein graft failure with 1-year angiography and restenosis and stent thrombosis rates in drug-eluting stents [7–12, 66].
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions

3. Fig 2
In-hospital cost-specific data of the average patient after 1-stage hybrid coronary revascularization (HCR) versus complete revascularization with off-pump coronary artery bypass graft surgery (OPCAB).
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions